Health

FlatTech LLC Receives Innovative Technology Contract from Vizient for EpiFaith(R) Syringe for safer epidurals

Contract awarded for products that bring improvement to health care industry TAIPEI, Jan. 9, 2023 /PRNewswire/ -- FlatTech LLC announced its EpiFaith® Syringe for epidural has received an Innovative Technology contract from Vizient, Inc. the nation's largest member-dri...

2023-01-09 21:00 2032

Immorna Receives IND Clearance to Conduct a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine

MORRISVILLE, N.C., Jan. 9, 2023 /PRNewswire/ -- Immorna, a rapidly expanding biotechnology company, focusing on the development of multi-platform RNA-based therapeutics and vaccines, today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) ap...

2023-01-09 20:00 1669

Jacobio Completes First Patient Dosage of Aurora A Inhibitor JAB-2485 in U.S

BEIJING and SHANGHAI and BOSTON, Jan. 8, 2023 /PRNewswire/ -- Jacobio Pharma (1167.HK) announced it has completedthe first patient dosage of its in-house R&D drug candidate Aurora A Inhibitor JAB-2485 in a Phase I/IIa clinical trial for advanced solid tumour patients in U.S. JAB-2485 is a high...

2023-01-08 14:17 3348

Fosun Pharma and Henlius Entered into an Exclusive License Agreement for Serplulimab in the US

PRINCETON, N.J., Jan. 7, 2023 /PRNewswire/ -- Fosun Pharma (600196.SH, 02196.HK) has recently entered into an exclusive license agreement with Shanghai Henlius Biotech, Inc. (2696.HK) for the commercialisation of Henlius independently developed anti-PD-1 monoclonal antibody (mAb) serplulimab inth...

2023-01-07 17:29 3686

International Captive Exchange, A Health In Tech Company, Becomes Managing General Underwriter (MGU) for Liberty Mutual Insurance Company

STUART, Fla., Jan. 6, 2023 /PRNewswire/ -- International Captive Exchange, LLC (ICE), a Health In Tech, Inc. company, an industry-leading Insurtech company that delivers disruptive innovation and proprietary technology, has entered into an agreement to serve as the Managing General Underwriting f...

2023-01-06 21:00 2146

Ocedurenone (KBP-5074) Featured at ASN Kidney Week: Ocedurenone is a Potential New Treatment Option for Patients with Uncontrolled or Resistant Hypertension and Advanced CKD

Hepatic Impairment and Drug-Drug Interaction Study Results Presented PRINCETON, N.J., Jan. 6, 2023 /PRNewswire/ -- KBP Biosciences PTE. Ltd. ("KBP Biosciences" or the "Company"), a clinical-stage biotechnology company dedicated to research, development, and commercialization of innovative medici...

2023-01-06 21:00 1981

Alterity Therapeutics Announces 1-for-10 Reverse ADS Split (consolidation)

MELBOURNE, Australia and SAN FRANCISCO, Jan. 6, 2023 /PRNewswire/ -- Alterity Therapeutics Limited ("Alterity" or the "Company") (ASX:ATH, NASDAQ:ATHE), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that its Board of D...

2023-01-06 20:25 3668

Premium Ski Goggles Exceed Industry Quality Standards During Testing

Outdoor Master is already an official supplier for the US Ski Team — r ely on  its excellent quality and technology . SHENZHEN, China, Jan. 6, 2023 /PRNewswire/ -- A brand dedicated to providing high-quality outdoor gear at reasonable prices, Outdoor Master ,  reached ...

2023-01-06 20:01 1714

Double-blind period completes! Primary endpoint analysis of phase 3 clinical trial to be conducted for China's first hormone replacement treatment targeting hypoparathyroidism

Submission of NDA to the NMPA is planned within 2023 at the earliest SHANGHAI, Jan. 6, 2023 /PRNewswire/ -- VISEN Pharmaceuticals, an innovative biopharmaceutical company focused on endocrine diseases, announced today that it has completed the double-blind period of PaTHway China Trial, a phase 3...

2023-01-06 18:00 1574

SK Biopharmaceuticals CEO Donghoon Lee Buys 3,000 Shares of Company Stock

- CEO shows commitment and confidence in the company's future through share purchase PANGYO, South Korea, Jan. 5, 2023 /PRNewswire/ -- SK Biopharmaceuticals, an innovative global pharmaceutical company, today announced that Mr.Donghoon Lee, the Chief Executive Officer and President of SK Biophar...

2023-01-06 09:10 1507

WAYCEN, the first medical AI company to win 4 CES 2023 innovation awards "Proved K-Medtech"

* Company specialized in AI Medtech, WAYCEN, won CES innovation awards for two years in a row * WAYCEN swept CES 2023 innovation awards with medical AI products, collaborated with the medical staff SEOUL, South Korea, Jan. 5, 2023 /PRNewswire/ -- The company specialized in AI Medtech, WAYCEN ...

2023-01-06 00:00 1732

Global Times: China shifts COVID policy with necessary conditions

BEIJING, Jan. 5, 2023 /PRNewswire/ -- After three years' hard efforts to keep COVID-19 at bay,China has optimized its virus response and come up with a major shift in its epidemic policy by downgrading COVID management and announcing the reopening of international borders fromJanuary 8, 2023. Glo...

2023-01-05 23:21 1914

Standigm cited as 'Top 10 Generative AI-based startup based on VC Investment, 2019-2021' in Gartner® report

SEOUL, South Korea, Jan. 5, 2023 /PRNewswire/ -- Standigm , a company using artificial intelligence (AI) technology for drug discovery and development, today announced that it had been cited in the 2022 Gartner Emerging Tech: Venture Capital Growth Insights for Gen...

2023-01-05 22:00 1713

Yunji Successfully Concludes its New Year Festive Goods Shopping Festival

HANGZHOU, China, Jan. 5, 2023 /PRNewswire/ -- Yunji Inc. ("Yunji" or the "Company") (NASDAQ: YJ), a leading membership-based social e-commerce platform, today announced that the final large-scale promotional event before the Lunar New Year, the New Year Festive Goods Shopping Festival ("the Event...

2023-01-05 19:00 3218

So-Young Regains Compliance with Nasdaq Minimum Bid Price Requirement

BEIJING, Jan. 5, 2023 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced that it has received a written...

2023-01-05 18:30 2929

B dot Medical to Install Its First Practical Ultra-compact Proton Therapy System at Hospital in Tokyo

- Memorandum of Understanding Signed with Edogawa Hospital - TOKYO, Jan. 5, 2023 /PRNewswire/ -- B dot Medical Inc. has signed a memorandum of understanding with Edogawa Hospital inJapan for the installation of the company's first practical ultra-compact proton therapy system, which means the fi...

2023-01-05 15:00 1674

Ascentage Pharma to Present at the 41st Annual J.P. Morgan Healthcare Conference

SUZHOU, China and ROCKVILLE, Md., Jan. 4, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its Chairman and CEO, Dr.Dajun Yang, has accep...

2023-01-05 09:00 2339

Duality Biologics Announces License Agreement of its Next-generation ADC platform with Adcendo

* Duality to grant license of DITAC (Duality Immune Toxin Antibody Conjugates) platform to Adcendo for its lead uPARAP ADC program * Duality to receive upfront payment, development, regulatory and commercial milestones, and tiered royalties * Collaboration based on synergies between Adcendo ...

2023-01-05 09:00 1271

Innovent to Present at 41st Annual J.P. Morgan Healthcare Conference

ROCKVILLE, Md. and SUZHOU, China, Jan. 4, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, o...

2023-01-05 00:00 2718

Lunit to Supply AI Solution for Chest X-Ray Analysis to Albert Einstein, Latin America's Largest Hospital

* Lunit signed a software license agreement with the Hospital Israelita Albert Einstein,Latin America's top medical institution, to provide its AI-based chest x-ray solution * Under the agreement, Lunit will supply its AI solution for chest x-ray image analysis to the Hospital Israelita Alber...

2023-01-04 21:20 2419
1 ... 108109110111112113114 ... 273